Ketoconazole Pinewood Laboratories (Ketoconazole)

Ketoconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of the fungal cell membrane. By blocking ergosterol production, the drug disrupts membrane integrity, leading to increased permeability and fungal cell death.

The specific dose and frequency are determined by the prescribing healthcare professional based on the type and severity of the infection, the patient’s age, and the area of skin involved. Users should follow the prescriber’s instructions and the product label.

Safety data for topical ketoconazole in pregnancy and lactation are limited. Healthcare providers usually weigh the potential benefits against any possible risks. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their clinician before starting treatment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ketoconazole belongs to the azole class, which inhibits ergosterol synthesis. Compared with allylamine agents such as terbinafine, azoles have a broader spectrum against yeasts and dermatophytes but may be more prone to causing local irritation. Choice of therapy depends on the specific pathogen, infection site, patient tolerance and clinician preference.

Ketoconazole Pinewood Laboratories should be stored at room temperature, below 25 °C. Keep the tube or container in its original packaging, protect it from moisture, heat and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

The medication is applied topically to the affected skin area, usually once or twice daily as directed by a healthcare professional. The skin should be clean and dry before application. A thin layer is spread gently and allowed to absorb; hands should be washed after use.

Serious but rare risks include allergic contact dermatitis, severe skin reactions such as Stevens‑Johnson syndrome, and systemic toxicity like hepatotoxicity if significant absorption occurs. Patients should discontinue use and seek medical attention if they notice severe rash, swelling, fever, or signs of liver dysfunction.

Individuals with a known hypersensitivity to ketoconazole or any component of the formulation should avoid using the product. It is also contraindicated on extensive broken skin, in patients with severe liver disease, and in those taking systemic azole antifungals without medical supervision.